A number of firms have modified their ratings and price targets on shares of fuboTV (NYSE: FUBO) recently: 6/21/2026 – fuboTV was downgraded by Wall Street Zen from “hold” to “sell”. 6/13/2026 – fuboTV was upgraded by Wall Street Zen from “sell” to “hold”. 6/12/2026 – fuboTV had its “buy” rating reaffirmed by Needham & […]

A number of research firms have changed their ratings and price targets for Natera (NASDAQ: NTRA): 6/23/2026 – Natera had its price target raised by BTIG Research from $250.00 to $270.00. They now have a “buy” rating on the stock. 6/11/2026 – Natera is now covered by Royal Bank Of Canada. They set an “outperform” […]

A number of research firms have changed their ratings and price targets for Rockwell Automation (NYSE: ROK): 6/16/2026 – Rockwell Automation is now covered by DA Davidson. They set a “neutral” rating and a $500.00 price target on the stock. 6/15/2026 – Rockwell Automation is now covered by DA Davidson. They set a “neutral” rating […]

uniQure (NASDAQ: QURE) has recently received a number of price target changes and ratings updates: 6/18/2026 – uniQure had its price target raised by Royal Bank Of Canada from $35.00 to $65.00. They now have an “outperform” rating on the stock. 6/18/2026 – uniQure had its “buy” rating reaffirmed by HC Wainwright. 6/18/2026 – uniQure […]

Commercial Metals (NYSE: CMC) recently received a number of ratings updates from brokerages and research firms: 6/22/2026 – Commercial Metals had its price target raised by Morgan Stanley from $83.00 to $88.00. They now have an “overweight” rating on the stock. 6/12/2026 – Commercial Metals was downgraded by Zacks Research from “hold” to “strong sell”. […]

Several analysts have recently updated their ratings and price targets for Agilent Technologies (NYSE: A): 6/11/2026 – Agilent Technologies is now covered by Piper Sandler. They set a “neutral” rating and a $150.00 price target on the stock. 6/3/2026 – Agilent Technologies had its price target lowered by HSBC Holdings plc from $180.00 to $165.00. […]

Several analysts have recently updated their ratings and price targets for Zevra Therapeutics (NASDAQ: ZVRA): 6/23/2026 – Zevra Therapeutics had its “buy” rating reaffirmed by HC Wainwright. They now have a $26.00 price target on the stock. 6/10/2026 – Zevra Therapeutics had its price target raised by Guggenheim from $25.00 to $29.00. They now have […]